Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial.
Spaas M, Sundahl N, Kruse V, Rottey S, De Maeseneer D, Duprez F, Lievens Y, Surmont V, Brochez L, Reynders D, Danckaert W, Goetghebeur E, Van den Begin R, Van Gestel D, Renard V, Dirix P, Ost P. Spaas M, et al. Among authors: van gestel d. JAMA Oncol. 2023 Sep 1;9(9):1205-1213. doi: 10.1001/jamaoncol.2023.2132. JAMA Oncol. 2023. PMID: 37410476 Clinical Trial.
Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.
Nuyts S, Lambrecht M, Duprez F, Daisne JF, Van Gestel D, Van den Weyngaert D, Platteaux N, Geussens Y, Voordeckers M, Madani I, De Neve W. Nuyts S, et al. Among authors: van den weyngaert d, van gestel d. Radiother Oncol. 2013 Nov;109(2):323-9. doi: 10.1016/j.radonc.2013.06.044. Epub 2013 Aug 13. Radiother Oncol. 2013. PMID: 23953410 Clinical Trial.
A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory.
Schatteman J, Van Gestel D, Berwouts D, De Gersem W, De Kerf G, De Neve W, De Ost B, Olteanu AML, Rottey S, Vercauteren T, Goethals I, Duprez F. Schatteman J, et al. Among authors: van gestel d. Strahlenther Onkol. 2018 Aug;194(8):727-736. doi: 10.1007/s00066-018-1293-3. Epub 2018 Mar 19. Strahlenther Onkol. 2018. PMID: 29556677 Clinical Trial. English.
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
Spaas M, Sundahl N, Hulstaert E, Kruse V, Rottey S, De Maeseneer D, Surmont V, Meireson A, Brochez L, Reynders D, Goetghebeur E, Van den Begin R, Van Gestel D, Renard V, Dirix P, Mestdagh P, Ost P. Spaas M, et al. Among authors: van gestel d, van den begin r. BMC Cancer. 2021 May 7;21(1):514. doi: 10.1186/s12885-021-08088-w. BMC Cancer. 2021. PMID: 33962592 Free PMC article.
Evaluation of the XVI dual registration tool for image-guided radiotherapy in prostate cancer.
Sousa F, Jourani Y, Van den Begin R, Otte FX, Ridai S, Desle M, Ferreira A, Ahmimed R, van Klink-de Goeij MCM, Van Gestel D. Sousa F, et al. Among authors: van gestel d, van den begin r, van klink de goeij mcm. Tech Innov Patient Support Radiat Oncol. 2021 Apr 20;18:22-28. doi: 10.1016/j.tipsro.2021.03.003. eCollection 2021 Jun. Tech Innov Patient Support Radiat Oncol. 2021. PMID: 33997323 Free PMC article.
Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study.
Baré M, Poeta S, Fernandes P, Jourani Y, Otte FX, Van Brussel S, Van Gestel D, Van den Begin R. Baré M, et al. Among authors: van gestel d, van brussel s, van den begin r. Phys Imaging Radiat Oncol. 2022 Jul 30;23:127-133. doi: 10.1016/j.phro.2022.07.006. eCollection 2022 Jul. Phys Imaging Radiat Oncol. 2022. PMID: 35941862 Free PMC article.
78 results